Noveome Biotherapeutics initiates trial evaluating intranasal delivery of ST266 targeting optic nerve and brain

Image: Noveome Biotherapeutics has initiated trial evaluating intranasal delivery of ST266 targeting optic nerve and brain. Photo: courtesy of VSRao from Pixabay.